Evidence method
Level · gp.fundamentals.capex_revenue_ratio
1.18% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
XLO · Dec 31, 2025
Xilio Therapeutics, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001193125-26-118550General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-11.41% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
589.88% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-95.92% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
128.04% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
15.85% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History5 statesHistory building
Period transition
What moved in the state?
- Previous
- 0.00%
- Current
- 1.18%
- Delta
- 1.18%
- Previous
- -91.76%
- Current
- -11.41%
- Delta
- 80.35%
- Previous
- 742.51%
- Current
- 589.88%
- Delta
- -152.63%
- Previous
- -10.12%
- Current
- -95.92%
- Delta
- -85.81%
- Previous
- 75.11%
- Current
- 128.04%
- Delta
- 52.93%
- Previous
- 5.89%
- Current
- 15.85%
- Delta
- 9.96%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · XLO Fundamental State →Has State · Xilio Therapeutics, Inc. →Transitioned To · XLO Fundamental State →Transitioned To · XLO CAPEX_INTENSITY_INCREASED →Transitioned To · XLO CASH_GENERATION_INCREASED →Transitioned To · XLO GROWTH_DECREASED →Transitioned To · XLO PROFITABILITY_DECREASED →Transitioned To · XLO R_AND_D_INTENSITY_INCREASED →Transitioned To · XLO SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.